1. Allen, R. E, McCann, U. D., and Ricaurte, G. A. (1993). Persistent effects of (+) 3,4-methylenedioxymethamphetamine (MDMA, “Ecstasy”) on human sleep. Sleep, 16, 560–564.
2. Anonymous. (1992). Drug culture. Lancet, 339, 117. Barrett, P. J., and Taylor, G. T. (1993). “Ecstasy” ingestion: A case report of severe complications. Journal of the Royal Society of Medicine, 86, 233–234.
3. Battaglia, G., Yeh, S. Y., O’Hearn, E., Molliver, M. E., Kuhar, M. J., and DeSouza, E. B. (1987). 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: Quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. Journal of Pharmacology and Experimental Therapeutics, 242, 911–916.
4. Battaglia, G., Yeh, S. Y., and DeSouza, E. B. (1988). MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons. Pharmacology, Biochemistry and Behavior, 29, 269–274.
5. Beardsley, P. M., Balster, R. L., and Harris, L. S. (1986). Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys. Drug and Alcohol Dependence, 18, 149–157.